awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q39135887-9DA4AB40-D578-411D-BFD4-3CA3B9672182
Q39135887-9DA4AB40-D578-411D-BFD4-3CA3B9672182
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39135887-9DA4AB40-D578-411D-BFD4-3CA3B9672182
Asparaginase pharmacology: challenges still to be faced.
P2860
Q39135887-9DA4AB40-D578-411D-BFD4-3CA3B9672182
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39135887-9DA4AB40-D578-411D-BFD4-3CA3B9672182
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
213c11d3a40bfae52e9cfc373e5cc5f9752eb896
P2860
FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).